Antipsychotics for aggressive adolescents

Barriers to best practice

Elizabeth A. Pappadopulos, Sonja E. Siennick, Peter S. Jensen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In adolescents, antipsychotics are most often used to treat complex, comorbid conditions with core disruptive features. However, the literature guiding such practices is limited. Best practice guidelines bridging the gap between the evidence and clinical practice have been developed to promote the appropriate and safe use of antipsychotics in aggressive youths. Due to complex barriers that exist at the level of the physician, patient/family and organization, merely disseminating these guidelines will not likely change antipsychotic prescribing practices. Negative attitudes, time constraints, lack of staff training and resources, or adolescent/family nonadherence can impede the translation of best practice guidelines into routine practices. Efforts to implement best practice guidelines must address these barriers if changes in prescribing practices are to occur and be sustained.

Original languageEnglish (US)
Pages (from-to)85-98
Number of pages14
JournalExpert Review of Neurotherapeutics
Volume3
Issue number1
DOIs
StatePublished - Jan 2003
Externally publishedYes

Fingerprint

Practice Guidelines
Antipsychotic Agents
Family Physicians
Organizations
Guidelines

Keywords

  • Adolescents
  • Aggression
  • Antipsychotic medications
  • Barriers
  • Best practice guidelines
  • Dissemination and implementation of practice guidelines

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Antipsychotics for aggressive adolescents : Barriers to best practice. / Pappadopulos, Elizabeth A.; Siennick, Sonja E.; Jensen, Peter S.

In: Expert Review of Neurotherapeutics, Vol. 3, No. 1, 01.2003, p. 85-98.

Research output: Contribution to journalArticle

Pappadopulos, Elizabeth A. ; Siennick, Sonja E. ; Jensen, Peter S. / Antipsychotics for aggressive adolescents : Barriers to best practice. In: Expert Review of Neurotherapeutics. 2003 ; Vol. 3, No. 1. pp. 85-98.
@article{c6913912fcff4f9ab88017785cd0dd7d,
title = "Antipsychotics for aggressive adolescents: Barriers to best practice",
abstract = "In adolescents, antipsychotics are most often used to treat complex, comorbid conditions with core disruptive features. However, the literature guiding such practices is limited. Best practice guidelines bridging the gap between the evidence and clinical practice have been developed to promote the appropriate and safe use of antipsychotics in aggressive youths. Due to complex barriers that exist at the level of the physician, patient/family and organization, merely disseminating these guidelines will not likely change antipsychotic prescribing practices. Negative attitudes, time constraints, lack of staff training and resources, or adolescent/family nonadherence can impede the translation of best practice guidelines into routine practices. Efforts to implement best practice guidelines must address these barriers if changes in prescribing practices are to occur and be sustained.",
keywords = "Adolescents, Aggression, Antipsychotic medications, Barriers, Best practice guidelines, Dissemination and implementation of practice guidelines",
author = "Pappadopulos, {Elizabeth A.} and Siennick, {Sonja E.} and Jensen, {Peter S.}",
year = "2003",
month = "1",
doi = "10.1586/14737175.3.1.85",
language = "English (US)",
volume = "3",
pages = "85--98",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Antipsychotics for aggressive adolescents

T2 - Barriers to best practice

AU - Pappadopulos, Elizabeth A.

AU - Siennick, Sonja E.

AU - Jensen, Peter S.

PY - 2003/1

Y1 - 2003/1

N2 - In adolescents, antipsychotics are most often used to treat complex, comorbid conditions with core disruptive features. However, the literature guiding such practices is limited. Best practice guidelines bridging the gap between the evidence and clinical practice have been developed to promote the appropriate and safe use of antipsychotics in aggressive youths. Due to complex barriers that exist at the level of the physician, patient/family and organization, merely disseminating these guidelines will not likely change antipsychotic prescribing practices. Negative attitudes, time constraints, lack of staff training and resources, or adolescent/family nonadherence can impede the translation of best practice guidelines into routine practices. Efforts to implement best practice guidelines must address these barriers if changes in prescribing practices are to occur and be sustained.

AB - In adolescents, antipsychotics are most often used to treat complex, comorbid conditions with core disruptive features. However, the literature guiding such practices is limited. Best practice guidelines bridging the gap between the evidence and clinical practice have been developed to promote the appropriate and safe use of antipsychotics in aggressive youths. Due to complex barriers that exist at the level of the physician, patient/family and organization, merely disseminating these guidelines will not likely change antipsychotic prescribing practices. Negative attitudes, time constraints, lack of staff training and resources, or adolescent/family nonadherence can impede the translation of best practice guidelines into routine practices. Efforts to implement best practice guidelines must address these barriers if changes in prescribing practices are to occur and be sustained.

KW - Adolescents

KW - Aggression

KW - Antipsychotic medications

KW - Barriers

KW - Best practice guidelines

KW - Dissemination and implementation of practice guidelines

UR - http://www.scopus.com/inward/record.url?scp=0037229443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037229443&partnerID=8YFLogxK

U2 - 10.1586/14737175.3.1.85

DO - 10.1586/14737175.3.1.85

M3 - Article

VL - 3

SP - 85

EP - 98

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 1

ER -